Turkey's BIO Startup 2022 begins to receive applications
Turkey’s first and only biotechnology-themed acceleration program BIO Startup has started to receive applications for 2022.
Supported by the country’s Association of Research-Based Pharmaceutical Companies (AIFD) and conducted by ReDis Innovation, the BIO Startup Program will continue to receive applications until March 31, 2022. Bio-entrepreneurs to take part in the Saveprogram will get the opportunity to attend the Bio-entrepreneurship Camp where they will receive thematic training and mentorship from experts of the industry.
Following the Bio-entrepreneurship Camp, entrepreneurs selected after their presentations at BIO Startup Demo Day, which will be attended by top managers and investment decision-makers of global companies, will have the chance to come together with actors of the international ecosystem via one-on-one meetings.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
More on this story...
Today's issue
Company Spotlight
More Features in Biotechnology
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze